The median prices for selected costly hospital products dipped in 2014 as hospital supply-chain leaders continued to negotiate tougher deals and clamp down on physician-preference items.
Providers are considering investing in lung programs that focus on early diagnosis as well as care coordination that smoothly guides a patient from diagnosis to treatment and recovery.
UCSF Medical Center opened its new Mission Bay Campus to patients in early February, welcoming new employees—some of whom are robots.
Kaiser Permanente, in what it's calling the largest renewable energy buy to date for a healthcare organization, plans to purchase enough wind and solar power to supply half of the electricity it uses at its more than 500 buildings in California.
John Bardis, chairman and CEO of MedAssets, has resigned from the company, effectively immediately, for “personal reasons” related to family health issues, MedAssets said Tuesday.
Acquisitions contributed to a strong quarter for Premier, a publicly traded healthcare supply chain and performance services company. Now with more than $1 billion to invest in growth, the company is looking for more deals.
A division of Ohio-based Cardinal Health has been named in a whistle-blower lawsuit for alleged violations of federal healthcare fraud and abuse laws, according to a company Securities and Exchange Commission filing.
Premier, the Charlotte, N.C.-based provider of group purchasing services and quality improvement tools, has acquired the remaining 40% of the company that operates its direct sourcing business.
VHA and UHC, which already jointly own a group purchasing organization, are merging to gain capital as tight hospital budgets and demands for new data and analytics tools upend the traditional healthcare purchasing model.
Thermo Fisher Scientific's earnings, following a major acquisition, soared 75.7% to $601.2 million in the three months ended Dec. 31. The company saw a nearly 50% jump in earnings for 2014, ending the year with $1.9 billion in net income.
Cardinal Health raised its earnings outlook for fiscal 2015 after a strong second quarter boosted revenue 15% for the distributor of pharmaceuticals and manufacturer of medical and surgical products.
Hospitals are facing higher prices for spinal cord stimulators, used to treat patients with chronic pain, since two manufacturers launched more complex versions of the devices in 2013, according to the Modern Healthcare/ECRI Institute Technology Price Index.